AZLI vs TOBISo
"Gilead is also increasing its chances of taking more sales from the Novartis drug by launching head-to-head trials. The results, which are due in the middle of this year, will determine just how much switching will go on."
<a target=_blank class=ftalternatingbarlinklarge...